Article | Healthcare

Pioneering the future of life sciences with AI

Artificial intelligence (AI) is transforming the future of drug discovery. Accelerated computing with AI has launched an entirely new paradigm that is streamlining the investigation, assessment, and creation of new drugs and therapies. These capabilities can be applied to evidence-based treatments, disease prediction, and prevention, bringing tailored therapies into widespread use. However, the exponential growth of life sciences data has put pressure on organizations to evolve. By 2025, data volumes are expected to reach 200 zettabytes. Although this data holds the potential to enable the next scientific breakthrough, issues including computational bottlenecks, limited access to mission-critical information, and poor predictive validity are major roadblocks on the path to discovery.

HC - Solution Overview - Pioneering the future of life sciences with AI

Preview article

More articles

  • Article

    4-Step Action Plan To Equip Data Scientists For The Hybrid World

    No matter where data teams are working from, they require high-performance computing power. But the quick fixes that IT relied on in the early days of hybrid work—like VDI and VPNs—just aren’t robust enough to meet these users’ compute-intensive needs.

  • Article harnesses the power of AI to revitalize the past

    Neural networks running on the HP Z8 Workstation create more authentic connections with priceless bygone moments.

  • Solution overview | FSI

    Unleasing the future of banking with AI

    The banking industry is undergoing a massive shift as companies work to improve the effectiveness of their operations.